Detalhe da pesquisa
1.
Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.
Hepatology
; 64(2): 370-80, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26799692
2.
Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2).
Hepatology
; 64(2): 360-9, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26704148
3.
Clinical and virological predictors of sustained response with an interferon-based simeprevir regimen for patients with chronic genotype 1 hepatitis C virus infection.
New Microbiol
; 40(1): 19-26, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28072888
4.
Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study.
J Antimicrob Chemother
; 71(1): 244-50, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26483516
5.
Simeprevir plus peginterferon/ribavirin for HCV genotype 1-infected treatment-naïve patients in China and South Korea.
J Gastroenterol Hepatol
; 31(5): 912-20, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-26777137
6.
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C.
Ann Hepatol
; 15(4): 512-23, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27236150
7.
Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir.
Antimicrob Agents Chemother
; 59(5): 2746-55, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25712364
8.
Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C.
Gastroenterology
; 146(3): 744-753.e3, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24316262
9.
An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay.
J Clin Microbiol
; 53(4): 1264-9, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25653396
10.
Risk factors predictive of anemia development during telaprevir plus peginterferon/ribavirin therapy in treatment-experienced patients.
J Hepatol
; 60(6): 1112-7, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24486089
11.
Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial.
Hepatology
; 58(6): 1897-906, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24382638
12.
Pharmacokinetic interaction between telaprevir and methadone.
Antimicrob Agents Chemother
; 57(5): 2304-9, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23478952
13.
Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results.
PLoS One
; 18(7): e0288271, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37467213
14.
The Hospital Recovery Scale: A clinically useful endpoint in patients hospitalized with influenza.
Contemp Clin Trials
; 123: 106952, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36202198
15.
Measuring respiratory syncytial virus infection severity in hospitalized children using the Pediatric Respiratory Syncytial Virus Electronic Severity and Outcome Rating System (PRESORS).
Influenza Other Respir Viruses
; 16(6): 1091-1100, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35965419
16.
Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post-discharge assessed by Respiratory Intensity and Impact Questionnaire.
Influenza Other Respir Viruses
; 16(1): 79-89, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34472708
17.
Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza-Related Hospitalizations in Adults-A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study).
Open Forum Infect Dis
; 8(11): ofab491, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35559130
18.
Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials.
J Antimicrob Chemother
; 65(11): 2450-4, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-20801782
19.
Pre-existence and Persistence of Resistant Minority Hepatitis C Virus Variants in Genotype 1-Infected Patients Treated With Simeprevir/Peginterferon/Ribavirin.
Open Forum Infect Dis
; 3(2): ofw052, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-27186579
20.
Ribavirin concentration determines treatment success of first-generation DAA-based chronic HCV therapy.
Antivir Ther
; 21(2): 153-9, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26378941